Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Mar 2026 is 3.49% vs 0.20% in Dec 2025
Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is 24.59% vs -11.92% in Dec 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Mar 2026 is 7.30% vs -3.19% in Dec 2025
Interest
QoQ Growth in quarter ended Mar 2026 is -10.08% vs -19.05% in Dec 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
Compare Quarterly Results Of Dermapharm Holding SE With
Quarterly - Net Sales
QoQ Growth in quarter ended Mar 2026 is 3.49% vs 0.20% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 1.12% vs 1.24% in Mar 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is 24.59% vs -11.92% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 35.84% vs -22.97% in Mar 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Mar 2026 is 7.30% vs -3.19% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 12.47% vs -8.37% in Mar 2025
Quarterly - Interest
QoQ Growth in quarter ended Mar 2026 is -10.08% vs -19.05% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -17.05% vs -16.77% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025






